Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man.

× No keyword cloud information.

18 in total

1. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials.

Authors: Shun Kishimoto; Nobu Oshima; Matthew Rinker; Murali C Krishna; Naoko Takebe
Journal: Eur J Cancer Date: 2019-05-24 Impact factor: 9.162

2. Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.

Authors: L Facci; S D Skaper; D Presti; G Kirschner; A Leon; L Chieco-Bianchi
Journal: Clin Exp Metastasis Date: 1990 Mar-Apr Impact factor: 5.150

3. Vincristine neuropathy: an electrophysiological and histological study.

Authors: J G McLeod; R Penny
Journal: J Neurol Neurosurg Psychiatry Date: 1969-08 Impact factor: 10.154

4. [Clinical and physiopathological effects of Vincristine on the nervous system].

Authors: H J Freund; K Kendel; P Obrecht
Journal: Dtsch Z Nervenheilkd Date: 1969-10

Review 5. Vincristine neurotoxicity. Pathophysiology and management.

Authors: S S Legha
Journal: Med Toxicol Date: 1986 Nov-Dec

6. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.

Authors: Stefanie Geisler; Ryan A Doan; Amy Strickland; Xin Huang; Jeffrey Milbrandt; Aaron DiAntonio
Journal: Brain Date: 2016-10-25 Impact factor: 13.501

7. Neuraxonal dystrophy of the brain in patients receiving antineoplastic chemotherapy.

Authors: H M Liu; J Loew; J Boggs
Journal: Acta Neuropathol Date: 1977-03-31 Impact factor: 17.088

8. Vindesine. A clinical trial with special reference to neurological side effects.

Authors: R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

9. Retardation of rat sciatic nerve regeneration after local application of minute doses of vincristine.

Authors: G S Ruigt; M H den Brok
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

10. Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.

Authors: S Koeppen; C C P Verstappen; R Körte; M E Scheulen; D Strumberg; T J Postma; J J Heimans; P C Huijgens; B Kiburg; K Renzing-Köhler; H C Diener
Journal: J Cancer Res Clin Oncol Date: 2004-01-16 Impact factor: 4.553